Previously, the primary procedure for prostate cancer diagnosis was transrectal ultrasound (TRUS)-guided systematic biopsy based on prostate-specific antigen (PSA) levels and digital rectal examination (DRE) findings. Here, KLK3 is linked to prostate carcinoma.